Sign inJoin waitlistJoin the waitlist

Todd Cooper

Section Chief · University of Washington School of Medicine

Credentials: · · · · · ·

History

University of Washington School of Medicine
Present
Oncology Section · Seattle Children's
Present
University of Washington School of Medicine
Present

Pediatrics
1998–2001
Doctor of Osteopathic Medicine
1994–1998

Research

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Journal of Clinical Oncology · 2016 · 488 citations
The genomic landscape of juvenile myelomonocytic leukemia
Nature Genetics · 2015 · 240 citations
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy
Blood · 2019 · 238 citations

EK
Edward Kolb
29 papers
Soheil Meshinchi
26 papers · 6 as a fellow
Richard Aplenc
22 papers
Alan Gamis
21 papers
Katherine Tarlock
18 papers · 1 as a fellow
Jessica Pollard
17 papers
Lia Gore
12 papers
Andrew Place
11 papers
Sarah Tasian
11 papers
Mignon Loh
10 papers
Lewis Silverman
7 papers
MS
Maria Sulis
7 papers

Clinical trials

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Principal investigator · Recruiting · Phase 3
Children's Oncology Group
2020–2029
Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Completed · Phase 1, Phase 2
Children's Oncology Group
2016–2023
A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene
Principal investigator · Completed · Phase 1
Epizyme, Inc.
2014–2016
AC220 for Children With Relapsed/Refractory ALL or AML
Study chair · Completed · Phase 1
Therapeutic Advances in Childhood Leukemia Consortium
2011–2013